ST. LOUIS, June 2, 2015 /PRNewswire/ -- Express Scripts (Nasdaq: ESRX) announced that it will present at the William Blair 35th Annual Growth Stock Conference on Tuesday, June 9, 2015 at 10:10 a.m. CT (11:10 a.m. ET).

The presentation will be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Player is needed to listen to the Webcast and free downloads of these players are available at the Webcast site. The Webcast will be archived and available for replay for 14 days.

Express Scripts (NASDAQ: ESRX) manages more than one billion prescriptions each year for tens of millions of patients. On behalf of our clients - employers, health plans, unions and government health programs - we make use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities - behavioral sciences, clinical specialization and actionable data - to create Health Decision Science®, our innovative approach to help individuals make the best benefit choices, drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/express-scripts-to-present-at-the-william-blair-35th-annual-growth-stock-conference-300092975.html

SOURCE Express Scripts

Jim Havel, Interim Chief Financial Officer, Chris McGinnis, Vice President Investor Relations, (314) 810-3115, investor.relations@express-scripts.com

distributed by